Their website said they have been providing epa for two outs of three biggest US icosapent ethyl clients (not sure who they are and what product/drug). Note their production only been 45 tons per year (by the way Taiwan uses metric ton). So either they are bragging about their clients or the supply is not exclusive. They are very keen at epa market, there were series news under their ticker about amrn case vs generics and they could not wait to expand their capacity...
Market Data 
Markets 
AI
